627 related articles for article (PubMed ID: 8537166)
41. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.
Stewart S; Jablonowski H; Goebel FD; Arasteh K; Spittle M; Rios A; Aboulafia D; Galleshaw J; Dezube BJ
J Clin Oncol; 1998 Feb; 16(2):683-91. PubMed ID: 9469358
[TBL] [Abstract][Full Text] [Related]
42. Kaposi's sarcoma in HIV infection treated with vincristine and bleomycin.
Gompels MM; Hill A; Jenkins P; Peters B; Tomlinson D; Harris JR; Stewart S; Pinching AJ; Munro AJ
AIDS; 1992 Oct; 6(10):1175-80. PubMed ID: 1281643
[TBL] [Abstract][Full Text] [Related]
43. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
44. A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma.
Nasti G; Errante D; Santarossa S; Vaccher E; Tirelli U
Drug Saf; 1999 May; 20(5):403-25. PubMed ID: 10348092
[TBL] [Abstract][Full Text] [Related]
45. Assessing the outcomes of HIV-infected persons receiving treatment for Kaposi sarcoma in Conakry-Guinea.
Bekolo CE; Soumah MM; Tiemtore OW; Diallo A; Yuma JD; Di Stefano L; Metcalf C; Cisse M
BMC Cancer; 2017 Dec; 17(1):806. PubMed ID: 29197357
[TBL] [Abstract][Full Text] [Related]
46. Results of chemotherapy in 30 AIDS patients with symptomatic pulmonary Kaposi's sarcoma.
Cadranel JL; Kammoun S; Chevret S; Parrot A; Denis M; Winter C; Carette MF; Rozenbaum W; Akoun GM; Mayaud CM
Thorax; 1994 Oct; 49(10):958-60. PubMed ID: 7526480
[TBL] [Abstract][Full Text] [Related]
47. Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: a Pediatric Oncology Group (POG) study.
Tebbi CK; Mendenhall N; London WB; Williams JL; de Alarcon PA; Chauvenet AR;
Pediatr Blood Cancer; 2006 Feb; 46(2):198-202. PubMed ID: 16136581
[TBL] [Abstract][Full Text] [Related]
48. Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma.
Friedman-Kien AE; Saltzman BR
J Am Acad Dermatol; 1990 Jun; 22(6 Pt 2):1237-50. PubMed ID: 2193952
[TBL] [Abstract][Full Text] [Related]
49. Treatment outcomes of AIDS-associated Kaposi's sarcoma under a routine antiretroviral therapy program in Lilongwe, Malawi: bleomycin/vincristine compared to vincristine monotherapy.
Mwafongo AA; Rosenberg NE; Ng'ambi W; Werner AB; Garneau WM; Gumulira J; Phiri S; Hosseinipour MC
PLoS One; 2014; 9(3):e91020. PubMed ID: 24632813
[TBL] [Abstract][Full Text] [Related]
50. Triple therapy of vincristine, bleomycin and etoposide for children with Kaposi sarcoma: Results of a study in Malawian children.
Macken M; Dale H; Moyo D; Chakmata E; Depani S; Israels T; Niyrenda D; Bailey S; Chagaluka G; Molyneux EM
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28988435
[TBL] [Abstract][Full Text] [Related]
51. Combination chemotherapy and alpha-interferon in the treatment of Kaposi's sarcoma associated with acquired immune deficiency syndrome.
Shepherd FA; Evans WK; Garvey B; Read SE; Klein M; Fanning MM; Coates R
CMAJ; 1988 Oct; 139(7):635-9. PubMed ID: 2458177
[TBL] [Abstract][Full Text] [Related]
52. Treatment of advanced, progressive epidemic Kaposi's sarcoma (EKS): a phase-II study.
Mitrou PS; Fischer C; Huhn D; Rasokat H; Ring J; Bergmann L
Onkologie; 1988 Feb; 11(1):61-2. PubMed ID: 2452394
[TBL] [Abstract][Full Text] [Related]
53. Antibody to the AIDS virus in Kaposi's sarcoma in Nigeria.
Otu AA
J Surg Oncol; 1988 Mar; 37(3):152-5. PubMed ID: 3162540
[TBL] [Abstract][Full Text] [Related]
54. Real-world use of chemotherapy for Kaposi's sarcoma in a large community-based HIV primary care system in Kenya.
Freeman EE; Busakhala N; Regan S; Asirwa FC; Wenger M; Seth D; Moon KC; Semeere A; Maurer T; Wools-Kaloustian K; Bassett I; Martin J
BMC Cancer; 2020 Jan; 20(1):71. PubMed ID: 31996161
[TBL] [Abstract][Full Text] [Related]
55. Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study.
Evans SR; Krown SE; Testa MA; Cooley TP; Von Roenn JH
J Clin Oncol; 2002 Aug; 20(15):3236-41. PubMed ID: 12149296
[TBL] [Abstract][Full Text] [Related]
56. Treatment of Kaposi's sarcoma after solid organ transplantation.
Shepherd FA; Maher E; Cardella C; Cole E; Greig P; Wade JA; Levy G
J Clin Oncol; 1997 Jun; 15(6):2371-7. PubMed ID: 9196152
[TBL] [Abstract][Full Text] [Related]
57. Raynaud phenomenon in three patients with acquired immune deficiency syndrome-related Kaposi sarcoma treated with bleomycin.
von Gunten CF; Roth EL; Von Roenn JH
Cancer; 1993 Sep; 72(6):2004-6. PubMed ID: 7689922
[TBL] [Abstract][Full Text] [Related]
58. Treatment of epidemic Kaposi's sarcoma with combination chemotherapy (vincristine and bleomycin) and zidovudine.
Rarick MU; Gill PS; Montgomery T; Bernstein-Singer M; Jones B; Levine AM
Ann Oncol; 1990; 1(2):147-9. PubMed ID: 1706615
[TBL] [Abstract][Full Text] [Related]
59. Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Gill PS
Semin Oncol; 1991 Oct; 18(5 Suppl 7):53-7. PubMed ID: 1719642
[TBL] [Abstract][Full Text] [Related]
60. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma.
Gill PS; Tulpule A; Espina BM; Cabriales S; Bresnahan J; Ilaw M; Louie S; Gustafson NF; Brown MA; Orcutt C; Winograd B; Scadden DT
J Clin Oncol; 1999 Jun; 17(6):1876-83. PubMed ID: 10561228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
